A medicine called levetiracetam may help control tremors in some MS patients.
Holmes' tremor is when your hands or arms shake at rest or when you try to move them. This can happen after a stroke or injury, and it's sometimes seen in people with multiple sclerosis (MS). Many treatments haven’t worked well for this condition, and some people even need surgery to feel better. However, in one case, a patient with Holmes' tremor saw a big improvement when they took levetiracetam, a medicine that is mainly used for seizures. This suggests that levetiracetam could be a new option for managing this type of tremor in MS patients.
MS patients who experience shaking or tremors in their arms or hands should pay attention to this finding because it could mean better control over their symptoms. Caregivers can also benefit by knowing that there might be new treatment options available. If a medicine like levetiracetam helps, it could allow patients to do everyday tasks more easily, like writing or holding objects. Doctors and healthcare providers should consider this information when looking for ways to help their patients feel more comfortable. Overall, this discovery could improve the quality of life for those affected by tremors due to MS.
The study only looked at one patient, so we need more research to see if levetiracetam works for others with similar symptoms. Not every MS patient will respond the same way to this treatment, so it’s important to talk to a doctor about options. Understanding that this is a single case means that while it's hopeful, it shouldn't be seen as a guaranteed solution for everyone experiencing tremors.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like BMJ case reports often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.